Evidence map›Paper›PMID 42811428›Full record

ArticleEmerging infectious diseases2026

Emergence of Macrolide-Resistant Bordetella pertussis, Peru, 2025.

Eduardo Juscamayta-López, Faviola Valdivia, Carmen Rodríguez-Cueva, Helen Horna, Yaneth Quispe, María Pía Soto, Segundo Torres, Victor Fiestas Solórzano, Martin Yagui, Vlademir Vicente Cantarelli and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Eduardo Juscamayta-López
Faviola Valdivia
Carmen Rodríguez-Cueva
Helen Horna
Yaneth Quispe
María Pía Soto
Segundo Torres
Victor Fiestas Solórzano
Martin Yagui
Vlademir Vicente Cantarelli
Efrain Montilla-Escudero
Víctor Silva
Ana Raquel Da Costa

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the emergence of macrolide-resistant Bordetella pertussis during a pertussis outbreak in Peru. Among 68 cases, 31% carried the A2047G gene mutation, conferring resistance to macrolides. Whole-genome sequencing revealed 2 genetically distinct groups, indicating multiple introductions into Peru. Our findings support strengthening surveillance for macrolide-resistant pertussis to inform control strategies.

Indexed as

Anti-Bacterial AgentsBordetella pertussisDrug Resistance, BacterialMacrolidesWhooping CoughDisease OutbreaksHumansMicrobial Sensitivity TestsMutationPeruWhole Genome SequencingAnti-Bacterial AgentsMacrolidesantimicrobial resistancebacteriaBordetella pertussismacrolide resistancemacrolidesmolecular epidemiologypertactinpertussisPerurespiratory infectionsvaccine-preventable diseaseswhooping cough

Identifiers

PMID42811428
PMCPMC13632835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.